Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.650
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
2.640
-0.010 (-0.38%)
After-hours: May 12, 2025, 4:35 PM EDT
Orchestra BioMed Holdings Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$14.20
Upside
+435.85%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +352.83% | May 5, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +654.72% | Apr 22, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +352.83% | Apr 4, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +654.72% | Apr 1, 2025 |
BTIG | BTIG | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +352.83% | Mar 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +428.30% | Mar 10, 2025 |
Barclays | Barclays | Buy Initiates $16 | Buy | Initiates | $16 | +503.77% | Jan 2, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +428.30% | Nov 15, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +654.72% | Nov 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +428.30% | Aug 22, 2024 |
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +466.04% | Jul 25, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +654.72% | Jun 12, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +654.72% | Mar 28, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +428.30% | Jan 19, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +654.72% | Aug 11, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +654.72% | Aug 9, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.